BLOSSOMHILL THERAPEUTICS, INC.

Transcripts BlossomHill Therapeutics, Inc.

Stocks

BLSM

US0951301003

Biotechnology & Medical Research

Real-time Estimate Cboe BZX 19:07:41 30/09/2026 +03			5-day change	1st Jan Change
19.04 ^USD	-10.93%		-14.06%	-

09-28	Blossomhill Therapeutics, Inc. Presents Preclinical Data on Novel Pan-KRAS Inhibitor, Bh-501284, At the AACR Conference on Pancreatic Cancer	CI
09-21	BlossomHill Therapeutics, Inc.(NasdaqGS:BLSM) added to S&P TMI Index	CI

Transcripts

No results match your criteria

All News Broker Recommendations Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies

Filters

Rankings

Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

The best tools reserved for subscribers to boost the performance of your investments!